Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.
Saved in:
| Title: | Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis. |
|---|---|
| Authors: | Boot AM; Department of Pediatric Endocrinology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen 9713 GZ, The Netherlands., Ariceta G; Department of Pediatric Nephrology, University Hospital Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain., Beck-Nielsen SS; Centre for Rare Diseases, Pediatric Department, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Brandi ML; FIRMO Foundation, Florence, Italy., Briot K; AP-HP, Department of Rheumatology, Cochin Hospital, Paris, France., Collantes CL; Pediatric Nephrology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain., Giannini S; Department of Medicine, Clinica Medica 1, University of Padova, Padova, Italy., Haffner D; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany., Keen R; Royal National Orthopaedic Hospital, Stanmore, UK., Levtchenko E; Department of Pediatric Nephrology, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Mughal MZ; Department of Pediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Mäkitie O; Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Nilsson O; Division of Pediatric Endocrinology, Center for Molecular Medicine, Department of Women's and Children's Health, Karolinska Institutet and University Hospital, Stockholm, Sweden.; Department of Pediatrics and School of Medical Sciences, Örebro University and University Hospital, Örebro, Sweden., Schnabel D; Center for Chronically Sick Children, Pediatric Endocrinology, Charitè, University Medicine, Berlin, Germany., Tripto-Shkolnik L; The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Tel HaShomer, Israel., Zillikens MC; Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Liu J; Kyowa Kirin International, Marlow, UK., Tudor A; Kyowa Kirin International, Marlow, UK., Emma F; Division of Nephrology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy. |
| Source: | Therapeutic advances in chronic disease [Ther Adv Chronic Dis] 2024 May 18; Vol. 15, pp. 20406223241247643. Date of Electronic Publication: 2024 May 18 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 101532140 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6223 (Print) Linking ISSN: 20406223 NLM ISO Abbreviation: Ther Adv Chronic Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
